LiverSource »  Faculty »  Medical Oncology »  Emily Bergsland, M.D.
 
Related Programs
Department of Surgery Websites

Make a Gift

A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.

How you can help »
LiverSource »  Faculty »  Medical Oncology »  Emily Bergsland, M.D.

Emily Bergsland, M.D.

Professor of Clinical Medicine
Division of Hematology Oncology
Department of Medicine

Contact Information

Academic Office
Telephone 415-353-7065
Fax 415-353-7150
emilyb@medicine.ucsf.edu

Clinical Practice
Gastrointestinal Surgery and Oncology Clinic
Colorectal Cancer Clinic
1600 Divisadero St., Fourth Floor
San Francisco, CA 94143-1705
Phone: (415) 353-9888
Fax: (415) 353-9931

Education

  • UniversUniversity of Wisconsin, B.S., 1985, Biochemistry and Molecular Biology
  • University of Minnesota, M.D., 1982

Residencies

  • 1989-92, Intern, Dept. of Medicine, University of California San Francisco
  • 1990-92, Resident, Dept. of Medicine, University of California San Francisco
  • 1992-92, Chief Resident and Assistant Chief of the Medical Service, Dept. of Medicine, University of California San Francisco

Fellowships

  • 1993-92, Fellow, Medical Oncology, University of California San Francisco

Postdoctoral Training

  • 1994-1992, Research Fellow (P I: Douglas Hanahan, Ph.D.), Department of Biochemistry and Biophysics, University of California San Francisco

Board Certification

  • American Board of Internal Medicine
  • American Board of Internal Medicine: Medical Oncology - Subspecialty

Program Affiliations

  • UCSF Helen Diller Family Comprehensive Cancer Center

Clinical Expertise

  • Colon Cancer
  • Esophageal Cancer
  • Hepatocellular Carcinoma (Liver Cancer)
  • Lynch Syndrome
  • Pancreatic Cancer
  • Rectal Cancer
  • Stomach Cancer

Research Interests

  • Angiogenesis Inhibitors
  • Colorectal Neoplasms
  • Neuroendocrine Tumors
  • Pancreatic Neoplasms
  • Vascular Endothelial Growth Factor

Biography

Dr. Emily Bergsland is a specialist in gastrointestinal oncology and an assistant clinical professor of medicine at UCSF. She earned her medical degree from the University of Minnesota and completed her residency and fellowship training at UCSF, joining the medical staff and faculty in 1996. Her clinical efforts are focused on developing and testing new cancer therapies.

Selected Publications

  1. Wang YC, Iezza G, Zuraek MB, Jablons DM, Theodore PR, Bergsland EK, Donner DB, Warren RS, Nakakura EK. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. J Surg Res. 2010 Sep; 163(1):47-51.
  2. Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK. Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg. 2010 Mar; 145(3):276-80.
  3. Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine. Endocr Relat Cancer. 2010; 17(1):283-91.
  4. Ko AH, Venook AP, Bergsland EK, Kelley RK, Korn WM, Dito E, Schillinger B, Scott J, Hwang J, Tempero MA. A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2010 Nov; 66(6):1051-7.
  5. Kulke MH, Bergsland EK, Yao JC. Glycemic control in patients with insulinoma treated with everolimus. N Engl J Med. 2009 Jan 8; 360(2):195-7.
View All Publications at UCSF Profiles (Powered by CTSI)

X